Literature DB >> 28678601

Adhesion structures in leukemia cells and their regulation by Src family kinases.

Pavla Röselová1, Adam Obr1, Aleš Holoubek1, Dana Grebeňová1, Kateřina Kuželová1.   

Abstract

Interaction of leukemia blasts with the bone marrow extracellular matrix often results in protection of leukemia cells from chemotherapy and in persistence of the residual disease which is on the basis of subsequent relapses. The adhesion signaling pathways have been extensively studied in adherent cells as well as in mature haematopoietic cells, but the adhesion structures and signaling in haematopoietic stem and progenitor cells, either normal or malignant, are much less explored. We analyzed the interaction of leukemia cells with fibronectin (FN) using interference reflection microscopy, immunofluorescence, measurement of adherent cell fraction, real-time microimpedance measurement and live cell imaging. We found that leukemia cells form very dynamic adhesion structures similar to early stages of focal adhesions. In contrast to adherent cells, where Src family kinases (SFK) belong to important regulators of focal adhesion dynamics, we observed only minor effects of SFK inhibitor dasatinib on leukemia cell binding to FN. The relatively weak involvement of SFK in adhesion structure regulation might be associated with the lack of cytoskeletal mechanical tension in leukemia cells. On the other hand, active Lyn kinase was found to specifically localize to leukemia cell adhesion structures and a less firm cell attachment to FN was often associated with higher Lyn activity (this unexpectedly occurred also after cell treatment with the inhibitor SKI-1). Lyn thus may be important for signaling from integrin-associated complexes to other processes in leukemia cells.

Entities:  

Keywords:  ECIS; Lyn; Src family kinases; adhesion; hematopoietic cell; leukemia

Mesh:

Substances:

Year:  2017        PMID: 28678601      PMCID: PMC6149513          DOI: 10.1080/19336918.2017.1344796

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  46 in total

Review 1.  Regulation of hematopoiesis through adhesion receptors.

Authors:  F Prosper; C M Verfaillie
Journal:  J Leukoc Biol       Date:  2001-03       Impact factor: 4.962

2.  Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces.

Authors:  J Wegener; C R Keese; I Giaever
Journal:  Exp Cell Res       Date:  2000-08-25       Impact factor: 3.905

3.  Localization of beta 1, beta 3, alpha 5, alpha v, and alpha IIb subunits of the integrin family in spreading human erythroleukemia cells.

Authors:  J Ylänne; D A Cheresh; I Virtanen
Journal:  Blood       Date:  1990-08-01       Impact factor: 22.113

4.  BCR-ABL1 alters SDF-1alpha-mediated adhesive responses through the beta2 integrin LFA-1 in leukemia cells.

Authors:  Ying-Yu Chen; Mobeen Malik; Brian E Tomkowicz; Ronald G Collman; Andrzej Ptasznik
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

5.  The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents.

Authors:  Cedric Dos Santos; Tinisha McDonald; Yin Wei Ho; Hongjun Liu; Allen Lin; Stephen J Forman; Ya-Huei Kuo; Ravi Bhatia
Journal:  Blood       Date:  2013-07-29       Impact factor: 22.113

Review 6.  Src signaling in cancer invasion.

Authors:  Marcello Guarino
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

7.  Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin.

Authors:  Katerina Kuzelová; Michaela Pluskalová; Barbora Brodská; Petra Otevrelová; Klára Elknerová; Dana Grebenová; Zbynek Hrkal
Journal:  J Cell Biochem       Date:  2010-01-01       Impact factor: 4.429

8.  Stretching single talin rod molecules activates vinculin binding.

Authors:  Armando del Rio; Raul Perez-Jimenez; Ruchuan Liu; Pere Roca-Cusachs; Julio M Fernandez; Michael P Sheetz
Journal:  Science       Date:  2009-01-30       Impact factor: 63.714

9.  Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin αIIbβ3 and Lyn Kinase.

Authors:  Huiying Zhi; Jing Dai; Junling Liu; Jieqing Zhu; Debra K Newman; Cunji Gao; Peter J Newman
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

10.  Essential Role of Lyn in Fibrosis.

Authors:  Hung Pham; Chiara Birtolo; Chintan Chheda; Wendy Yang; Maria D Rodriguez; Sandy T Liu; Gabriele Gugliotta; Michael S Lewis; Vincenzo Cirulli; Stephen J Pandol; Andrzej Ptasznik
Journal:  Front Physiol       Date:  2016-08-31       Impact factor: 4.566

View more
  5 in total

1.  Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.

Authors:  Sriram Sundaravel; Wen-Liang Kuo; Jong Jin Jeong; Gaurav S Choudhary; Shanisha Gordon-Mitchell; Hui Liu; Tushar D Bhagat; Kathy L McGraw; Sandeep Gurbuxani; Alan F List; Amit Verma; Amittha Wickrema
Journal:  Clin Cancer Res       Date:  2019-07-15       Impact factor: 12.531

2.  PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.

Authors:  Dana Grebeňová; Aleš Holoubek; Pavla Röselová; Adam Obr; Barbora Brodská; Kateřina Kuželová
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

3.  Group I p21-activated kinases in leukemia cell adhesion to fibronectin.

Authors:  Kateřina Kuželová; Adam Obr; Pavla Röselová; Dana Grebeňová; Petra Otevřelová; Barbora Brodská; Aleš Holoubek
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

4.  NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization.

Authors:  Markéta Šašinková; Petr Heřman; Aleš Holoubek; Dita Strachotová; Petra Otevřelová; Dana Grebeňová; Kateřina Kuželová; Barbora Brodská
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 5.  Epithelial Mesenchymal Transition (EMT) and Associated Invasive Adhesions in Solid and Haematological Tumours.

Authors:  David Greaves; Yolanda Calle
Journal:  Cells       Date:  2022-02-13       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.